Skip to main content

TATAA to Sell TriLink's CleanAmp Products

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – TriLink Biotechnologies last week entered into a distribution agreement with TATAA Biocenter, under which Gothenburg, Sweden-based TATAA will sell TriLink's CleanAmp products.

TATAA develops and performs hands-on qPCR courses worldwide and provides tailor-made products for real-time PCR applications, the firm said in a statement.

TriLink's CleanAmp product line helps resolve common PCR problems, such as primer-dimer formation and mispriming. TriLink said that the latest addition to the product line, improved CleanAmp dNTPs, will be available next month. This new product enables improved amplicon yield in endpoint PCR and earlier Cq values in fast-cycling real-time PCR, the company said.

Financial and other terms of the alliance were not disclosed.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.